Amir Belson, M.D., was the founder of Neoguide Systems, that was acquired by Intuitive Surgical in 2009, Vascular Pathways, a vascular intervention technology which was acquired by C R Bard, Zipline Medical, a wound closure technology company, Qool Therapeutics, a minimally invasive therapeutic hypothermia technology company, Radiaction Medical, a radiation protection medical device company, VasoStitch, which develops large vessel access and closure technology, Embolibe, which develops proprietary embolic protection technology, Modular Surgical which develops new minimally invasive surgery technology, Oxyvive, a chronic/diabetic wound care technology company and PAFA, that develops atrial fibrillation ablation technology.
Dr. Belson also serves as board director of Alter-G, Relometrics and QT Vascular.
Belson graduated cum laude from the school of medicine of the Technion, Israel Institute of Technology, in Haifa, Israel. He did his pediatric residency at Dana Children’s Hospital in Tel Aviv and his pediatric nephrology fellowship at Lucile Packard Children’s Hospital at Stanford University. Belson also spent one year as a research fellow with the Biomedical Technology Innovation Program at Stanford.
He is the author of 34 medical papers and abstracts and has more than 500 issued and pending patents.